Colestipol Hydrochloride

CAS 37296-80-3 6 current recordsSmall Molecule

Who holds supplier records for Colestipol Hydrochloride? 6 organisations hold a current record for Colestipol Hydrochloride: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4), Taiwan (1) and United States (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Colestipol Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/colestipol-hydrochloride

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    4 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Colestipol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Colestipol Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Colestipol Hydrochloride is a non-absorbable polymeric compound used as a bile acid sequestrant for the treatment of hypercholesterolemia and other related conditions. It binds with bile acids in the intestine to form a complex that is excreted, thereby reducing serum cholesterol levels.

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Bile Acid Sequestrant
Mechanism of action
Bile-acid Binding Activity

Therapeutic areas

CardiovascularLipid Metabolism Disorders

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Colestipol Hydrochloride?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Colestipol Hydrochloride: Formosa Laboratories, Inc. (Taiwan), RAKS PHARMA PVT LTD (India), RISING PHARMA HOLDINGS INC (United States), SOLARA ACTIVE PHARMA SCIENCES LTD (India), Sun Pharmaceutical Industries Limited (India) and Zydus Lifesciences Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Colestipol Hydrochloride Drug Master Files are active?

Formosa Laboratories, Inc. (DMF 17651), RAKS PHARMA PVT LTD (DMF 38026), RISING PHARMA HOLDINGS INC (DMF 33542), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 33423), Sun Pharmaceutical Industries Limited (DMF 39413) and Zydus Lifesciences Limited (DMF 33460). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Colestipol Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Colestipol Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.